Intact Chorionic Villus Sampling (ICVS): Definition, Procedure & Risks

Intact Chorionic Villus Sampling (ICVS) is a first-trimester prenatal diagnostic technique that obtains a contiguous villous tissue sample for genetic analysis. It's a variant of standard CVS designed to reduce maternal cell contamination and improve diagnostic yield for certain conditions.

Indications

  • Advanced maternal age (≥35)
  • Positive aneuploidy screen (NIPT, combined screen)
  • Prior child with chromosomal abnormality
  • Parental balanced translocation / inversion
  • Fetal structural anomaly on ultrasound
  • Family history of genetic disorder amenable to CVS testing

Procedure (10–13+6 weeks gestation)

  1. Ultrasound guidance: Continuous real-time. Confirms viability, placental location, fetal position.
  2. Route selection:
    • Transcervical: Catheter through cervix to placental bed. Preferred for anterior/fundal placenta.
    • Transabdominal: Needle through abdominal wall. Preferred for posterior placenta, retroverted uterus, cervical stenosis, infection risk.
  3. Intact sampling: Specialized catheter/needle obtains a contiguous villous fragment (vs. aspirated fragments in standard CVS), preserving tissue architecture.
  4. Sample processing: Villi separated from decidua (maternal tissue) under microscope — critical for reducing maternal cell contamination (MCC).
  5. Genetic analysis: Direct prep (FISH/PCR for rapid aneuploidy: 13, 18, 21, X, Y — 24–48 hrs), culture for karyotype (10–14 days), CMA (chromosomal microarray — detects microdeletions/duplications), targeted gene sequencing.

Advantages of Intact Sampling

  • Lower MCC rate (<1% vs. 1–2% standard CVS) — reduces false mosaicism / need for amniocentesis confirmation.
  • Better tissue for molecular studies (RNA, protein, epigenetics).
  • May improve detection of confined placental mosaicism (CPM) interpretation.

Risks

  • Procedure-related loss: ~0.2–0.5% (1:200–1:500) — slightly higher than amniocentesis (0.1–0.3%), operator-dependent.
  • Transient cramping, spotting (common).
  • Rh sensitization (RhIg given if Rh-negative).
  • Infection (rare).
  • Limb reduction defects — theoretical if <10 wks; not observed at 10+ wks.

CVS vs. Amniocentesis

CVS (ICVS)Amniocentesis
Gestational age10–13+6 wks15–20+ wks
SamplePlacental (trophoblast)Amniotic fluid (fetal cells)
MCC riskLow (lower with intact)Negligible
CPM detectionYesNo (fetal only)
Neural tube defectsNo (AF-AFP not available)Yes (AF-AFP)
Loss rate~0.2–0.5%~0.1–0.3%

Decision-Making

Choose CVS for earlier answers. Choose amnio for NTD screening, later gestation, or if CVS results ambiguous (CPM). Genetic counselor essential for pre/post-test counseling.

Bones, Joints & Muscles - Related Articles